TrialScientific reports2022

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.

Fiona Chionh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.